Chapter: 1: INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top winning strategis
3.2.3 Top investment pockets

3.3 Market share analysis, 2014
3.4 Government regulations and reimbursement scenario
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Technological advancements
3.5.1.2 Large scale adoption in research and diagnosis applications
3.5.1.3 Increasing applications across novel fields
3.5.1.4 Augmented R&D investment

3.5.2 Restraints

3.5.2.1 High cost of instrument
3.5.2.2 Limited technical expertise

3.5.3 Opportunities

3.5.3.1 Lucrative opportunities in diagnostics in other diseases
3.5.3.2 Emerging role of flow cytometry in drug discovery and development

Chapter: 4: AUSTRIA FLOW CYTOMETRY MARKET BY COMPONENT

4.1 Overview

4.1.1 Market size and forecast

4.2 Instruments

4.2.1 Key market trends
4.2.2 Competitive landscape
4.2.3 Key growth factors and opportunities
4.2.4 Market size and forecast
4.2.5 Platforms

4.2.5.1 Market size and forecast
4.2.5.2 Sorters

4.2.5.2.1 MARKET SIZE AND FORECAST

4.2.5.3 Analysers

4.2.5.3.1 MARKET SIZE AND FORECAST

4.2.6 Replaceable components

4.2.6.1 Market size and forecast
4.2.6.2 Filters

4.2.6.2.1 MARKET SIZE AND FORECAST

4.2.6.3 Lasers

4.2.6.3.1 MARKET SIZE AND FORECAST

4.2.6.4 Detectors

4.2.6.4.1 MARKET SIZE AND FORECAST

4.2.6.5 Others

4.2.6.5.1 MARKET SIZE AND FORECAST

4.2.7 Accessories

4.2.7.1 Market size and forecast

4.3 Reagents and consumables

4.3.1 Key market trends
4.3.2 Competitive landscape
4.3.3 Key growth factors and opportunities
4.3.4 Market size and forecast
4.3.5 Antibodies

4.3.5.1 Market size and forecast

4.3.6 Dyes

4.3.6.1 Market size and forecast

4.3.7 Beads

4.3.7.1 Market size and forecast

4.3.8 Others

4.3.8.1 Market size and forecast

4.4 Software

4.4.1 Key market trends
4.4.2 Competitive landscape
4.4.3 Key growth factors and opportunities
4.4.4 Market size and forecast

4.5 Services

4.5.1 Key market trends
4.5.2 Competitive landscape
4.5.3 Key growth factors and opportunities
4.5.4 Market size and forecast

Chapter: 5: AUSTRIA FLOW CYTOMETRY MARKET BY TECHNOLOGY

5.1 Overview

5.1.1 Market size and forecast

5.2 Bead-based flow cytometry

5.2.1 Key market trends
5.2.2 Competitive landscape
5.2.3 Key growth factors and opportunities

5.3 Cell based flow cytometers

5.3.1 Key market trends
5.3.2 Competitive landscape
5.3.3 Key growth factors and opportunities

Chapter: 6: AUSTRIA FLOW CYTOMETRY MARKET BY APPLICATION

6.1 Overview

6.1.1 Market size and forecast

6.2 Research applications

6.2.1 Key market trends
6.2.2 Competitive landscape
6.2.3 Key growth factors and opportunities
6.2.4 Market size and forecast
6.2.5 Cell cycle analysis and cell proliferation
6.2.6 Transfection and cell viability

6.3 Clinical applications

6.3.1 Key market trends
6.3.2 Competitive landscape
6.3.3 Key growth factors and opportunities
6.3.4 Market size and forecast
6.3.5 Apoptosis
6.3.6 Sorting/screening

6.4 Industrial applications

6.4.1 Key market trends
6.4.2 Competitive landscape
6.4.3 Key growth factors and opportunities
6.4.4 Market size and forecast
6.4.5 Organ transplantation
6.4.6 Hematological malignancies
6.4.7 Cancer and Solid Tumour
6.4.8 HIV
6.4.9 Others

Chapter: 7: AUSTRIA FLOW CYTOMETRY MARKET BY END USER

7.1 Overview

7.1.1 Market size and forecast

7.2 Commercial organizations

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities

7.3 Medical schools and clinical testing laboratories

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities

7.4 Hospitals

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities

7.5 Academic institutions

7.5.1 Key market trends
7.5.2 Key growth factors and opportunities

7.6 Others

Chapter: 8: COMPANY PROFILES

8.1 Danaher Corporation (Beckman Coulter)

8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Business performance
8.1.5 Key strategic moves and developments
8.1.6 SWOT analysis of Danaher Corporation

8.2 Becton, Dickinson And Co.

8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Business performance
8.2.5 Key strategic moves and developments
8.2.6 SWOT analysis of Becton, Dickinson and Co.

8.3 Merck Millipore

8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Business performance
8.3.4 Key strategic moves and developments
8.3.5 SWOT analysis of Merck Millipore

8.4 Bio-Rad Laboratories, Inc.

8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Business performance
8.4.5 Key strategic moves and developments
8.4.6 SWOT analysis of Bio-Rad Laboratories, Inc.

8.5 Dako (Agilent Technologies)

8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Business performance
8.5.5 Key strategic moves and developments
8.5.6 SWOT analysis of Agilent Technologies, Inc.

List of Figures

FIG. 1 TOP IMPACTING FACTORS (2014-2020)
FIG. 2 TOP WINNING STRATEGIES PERCENTAGE DISTRIBUTION
FIG. 3 TOP WINNING STRATEGIES BASED ON TYPE AND NATURE OF DEVELOPMENTS
FIG. 4 TOP INVESTMENT POCKETS
FIG. 5 MARKET SHARE ANALYSIS, 2014
FIG. 6 TYPES OF PLATFORMS
FIG. 7 ESTIMATED NEW CASES OF CANCER IN AUSTRIA (2014)
FIG. 8 NUMBER OF HIV CASES BASED ON LOCATION IN AUSTRIA, 2014
FIG. 9 DANAHER CORPORATION, % REVENUE BY BUSINESS SEGMENTS, (2014)
FIG. 10 DANAHER CORPORATION, % REVENUE BY GEOGRAPHY (2014)
FIG. 11 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 12 BECTON, DICKINSON AND CO., % REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 13 BECTON, DICKINSON AND CO., % REVENUE BY GEOGRAPHY (2014)
FIG. 14 SWOT ANALYSIS OF BECTON, DICKINSON AND CO.
FIG. 15 MERCK MILLIPORE, % REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 16 SWOT ANALYSIS OF MERCK MILLIPORE
FIG. 17 BIO-RAD LABORATORIES INC., REVENUE, 20122014, ($MILLION)
FIG. 18 BIO-RAD LABORATORIES INC., % REVENUES BY BUSINESS UNITS (2014)
FIG. 19 BIO-RAD LABORATORIES INC., % REVENUES BY GEOGRAPHY (2014)
FIG. 20 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
FIG. 21 AGILENT TECHNOLOGIES INC., %REVENUE BY BUSINESS UNITS, 2014 ($MILLION)
FIG. 22 AGILENT TECHNOLOGIES, INC. %REVENUE BY GEOGRAPHY (2014)
FIG. 23 SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC.

List of Tables

TABLE 1 AUSTRIA FLOW CYTOMETRY MARKET BY COMPONENT 2014-2020 ($THOUSANDS)
TABLE 2 AUSTRIA FLOW CYTOMETRY INSTRUMENTS MARKET BY TYPE 2014-2020 ($THOUSANDS)
TABLE 3 AUSTRIA FLOW CYTOMETRY PLATFORMS MARKET BY TYPE 2014-2020 ($THOUSANDS)
TABLE 4 TYPES OF PLATFORMS
TABLE 5 TYPES OF SORTERS:
TABLE 6 SORTERS BY KEY PLAYERS
TABLE 7 AUSTRIA FLOW CYTOMETRY SORTERS MARKET, 2014-2020 ($THOUSANDS)
TABLE 8 ANALYZERS BY KEY PLAYERS
TABLE 9 AUSTRIA FLOW CYTOMETRY ANALYZERS MARKET, 2014-2020 ($THOUSANDS)
TABLE 10 AUSTRIA FLOW CYTOMETRY REPLACEABLE COMPONENTS MARKET, 2014-2020 ($THOUSANDS)
TABLE 11 TYPES OF FILTERS
TABLE 12 AUSTRIA FLOW CYTOMETRY FILTERS MARKET 2014-2020 ($THOUSANDS)
TABLE 13 AUSTRIA FLOW CYTOMETRY LASERS MARKET, 2014-2020 ($THOUSANDS)
TABLE 14 TYPES OF DETECTORS
TABLE 15 AUSTRIA FLOW CYTOMETRY DETECTORS MARKET, 2014-2020 ($THOUSANDS)
TABLE 16 AUSTRIA FLOW CYTOMETRY OTHER COMPONENTS MARKET 2014-2020 ($THOUSANDS)
TABLE 17 AUSTRIA FLOW CYTOMETRY ACCESSORIES MARKET, 2014-2020 ($THOUSANDS)
TABLE 18 AUSTRIA FLOW CYTOMETRY REAGENTS AND CONSUMABLES MARKET BY PLATFORMS 2014-2020 ($THOUSANDS)
TABLE 19 AUSTRIA FLOW CYTOMETRY ANTIBODIES MARKET, 2014-2020 ($THOUSANDS)
TABLE 20 AUSTRIA FLOW CYTOMETRY DYES MARKET, 2014-2020 ($THOUSANDS)
TABLE 21 AUSTRIA FLOW CYTOMETRY BEADS MARKET, BY GEOGRAPHY 2014-2020 ($THOUSANDS)
TABLE 22 AUSTRIA FLOW CYTOMETRY OTHER REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY 2014-2020 ($THOUSANDS)
TABLE 23 AUSTRIA FLOW CYTOMETRY- SOFTWARE MARKET, 2014-2020 ($THOUSANDS)
TABLE 24 AUSTRIA FLOW CYTOMETRY SERVICES MARKET, BY GEOGRAPHY 2014-2020 ($THOUSANDSS)
TABLE 25 AUSTRIA FLOW CYTOMETRY MARKET, BY TECHNOLOGY 2014-2020 ($THOUSANDS)
TABLE 26 AUSTRIA FLOW CYTOMETRY MARKET, BY APPLICATIONS 2014-2020 ($THOUSANDS)
TABLE 27 AUSTRIA FLOW CYTOMETRY MARKET, BY RESEARCH APPLICATIONS 2014-2020 ($THOUSANDS)
TABLE 28 AUSTRIA FLOW CYTOMETRY MARKET, BY CLINICAL APPLICATIONS 2014-2020 ($THOUSANDS)
TABLE 29 AUSTRIA FLOW CYTOMETRY MARKET, BY INDUSTRIAL APPLICATIONS 2014-2020 ($THOUSANDS)
TABLE 30 AUSTRIA FLOW CYTOMETRY MARKET, BY END USER 2014-2020 ($THOUSANDS)
TABLE 31 COMPANY SNAPSHOT OF DANAHER CORPORATION
TABLE 32 DANAHER CORPORATION OPERATING SEGMENTS
TABLE 33 COMPANY SNAPSHOT OF BECTON, DICKINSON AND CO.
TABLE 34 BECTON, DICKINSON AND COMPANY OPERATING SEGMENTS
TABLE 35 SNAPSHOT OF MERCK MILLIPORE
TABLE 36 COMPANY SNAPSHOT OF BIO-RAD LABORATORIES, INC.
TABLE 37 BIO-RAD LABORATORIES, INC. OPERATING SEGMENTS
TABLE 38 COMPANY SNAPSHOT OF AGILENT TECHNOLOGIES, INC.
TABLE 39 AGILENT TECHNOLOGIES, INC OPERATING SEGMENTS